Cost-benefit, cost-effectiveness research of drug abuse prevention
Subtitle: implications for programming and policy
By: editors, William J. Bukoski, Richard I. Evans.
Contributors: Bukoski, William J.; Evans, Richard I.; National Institute on Drug Abuse. Division of Epidemiology and Prevention Research.; National Institutes of Health (U.S.)
Series: NIDA research monograph -- 176; NIH publication -- no. 98-4021
Publisher: U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research
Published: 1998
Place of publication: Rockville, MD
Language: eng
Number of pages: 233
Subjects: Substance-Related Disorders -- prevention & control; Substance-Related Disorders -- economics; Cost-Benefit Analysis
Notes: Includes bibliographical references.
Table of contents: title: Impact of substance abuse on federal spending; title: Historical perspective on effective prevention; title: School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness; title: Effectiveness of prevention interventions with youth at high risk of drug abuse; title: Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention; title: Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention; title: Analytic issues for estimating the benefits and costs of substance abuse prevention; title: Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings; title: Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth; title: Implications for prevention policy: a commentary.